Changes in the Content of Immunoreactive Dynorphin in Dorsal and Ventral Spinal Cord of the Rat in three Different Conditions

REFERENCE

• Botticelli L. J., Cox B. M., Goldstein A. Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia. Proceedings of the National Academy of Sciences, USA 1981; 78: 7783–7786
   PubMedGoogle Scholar
• Chavkin C., James I. F., Goldstein A. Dynorphin is a specific endogenous ligand of the K opioid receptor. Science 1982; 215: 413–415
   PubMed Web of Science ®Google Scholar
• Faden A. I., Jacobs T. P. Dynorphin induces partially reversible paraplegia in the rat. European Journal of Pharmacology 1983; 91: 321–324
   PubMedGoogle Scholar
• Faden A. I., Jaccb T. P., Holaday J. W. Opiate antagonist improves neurologic recovery after spinal injury. Science 1981; 211: 493–494
   PubMed Web of Science ®Google Scholar
• Faden A. I., Molineaux C. J., Rosenberger J. G., Jacobs T. P., Cox B. M. Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury. Annals of Neurology 1985; 17: 386–390IS
   PubMedGoogle Scholar
• Fei H., Xie G. X., Han J. S. Differential release of met-enkephalin and dynorphin in spinal cord by electroacupuncture of different frequencies. Kexue Tonbao 1986; 31: 1512–1515
   Google Scholar
• Ghazarossian V. E., Chavkin C., Goldstein A. A specific radioimmunoassay for the novel opioid pep tide dynorphin. Life Sciences 1980; 27: 75–86
   PubMed Web of Science ®Google Scholar
• Goldstein A., Tachibana S., Lowney L. I., Hunkapiller M., Hood L. Dynorphin-(1–13), an extraordinarily potent opioid peptide. Proceedings of the National Academy of Sciences, USA 1979; 76: 6666–6670
   PubMed Web of Science ®Google Scholar
• Han J. S., Chen X. H., Sun S. L., Xu X. J., Yuan Y., Yan S. C., Hao J. X., Terenius L. Effect of low- and high-frequency TENS on met-enkephalin-Arg-Phe- and dynorphin A immunoreactivity in human lumbar CSF. Pain 1991; 47: 295–298
   PubMed Web of Science ®Google Scholar
• Han J. S., Ding X. Z., Fan S. G. The frequency as the cardinal determinant for electroacupuncture analgesia to be reversed by opioid antagonists. Acta Physiologica Sinica 1986; 38: 475–482
   PubMedGoogle Scholar
• Han J. S., Xie C. W. Dynorphin: potent analgesic effect in spinal cord of the rat. Life Sciences 1982; 31: 1781–1784
   PubMed Web of Science ®Google Scholar
• Han J. S., Xie C. W. Dynorphin: potent analgesic effect in spinal cord of the rat. Scientia Sinica(Ser B) 1984a; 27: 169–177
   Google Scholar
• Han J. S., Xie G.-X. Dynorphin: Important mediator for electroacupuncture analgesia in the spinal cord of the rabbit. Pain 1984b; 18: 367–376
   PubMed Web of Science ®Google Scholar
• Herman B. M., Goldstein A. Antinociception and paralysis induced by intrathecal dynorphin A. Journal of Pharmacology and Experimental Therapeutics 1985; 232: 21–32
   Google Scholar
• Iadarola M. J., Brady L. S., Draisci G., Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain 1988a; 35: 313–326
   PubMed Web of Science ®Google Scholar
• Iadarala M. J., Douglass J., Civelli O., Naranjo J. R. Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization. Brain Research 1988b; 455: 205–212
   PubMedGoogle Scholar
• Iadarala M. J., Yang H. Y. T., Costa E. Increase in spinal cord dynorphin during an experimentally-induced inflammation of the rat hind limb. Federation Proceedings 1985; 44: 422
   Google Scholar
• Lowry O. H., Resebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Mansour A., Khachaturian H., Lewis M. E., Akil H., Watson S. J. Anatomy of CNS opioid receptors. Trends in Neuroscience 1988; 11: 308–314
   PubMed Web of Science ®Google Scholar
• Millan M. J., Millan M. H., Czlonkowski A., Hollt V., Pilcher C. W. T., Herz A., Colpaert F. C. A model of chronic pain in the rat: functional correlates of alterations in the activity of opioid systems. Journal of Neuroscience 1987; 7: 77–81
   PubMedGoogle Scholar
• Millan M. J., Millan M. H., Pilcher C. W. T., Czlonkowski A, Hen A., Colpaert F. C. Spinal cord dynorphin may modulate nociception via a K-opioid receptor in chronic arthritic rats. Brain Research 1985; 340: 156–159
   PubMedGoogle Scholar
• Morris B. J., Herz A. Autoradiographic distribution in rat brain of a non-conventional binding site for the opiate [3H]diprenorphine. Brain Research 1986; 384: 362–366
   PubMedGoogle Scholar
• Morris B. J., Herz A. Distinct distribution of opioid receptor types in rat lumbar spinal cord. Naunyn-Schmiedeberg's Aichives of Pharmacology 1987; 336: 240–243
   Google Scholar
• Przewlocki R., Haarmann I., Nikolarakis K., Herz A., Hollt V. Prodynorphin gene expression in spinal cord is enhanced after traumatic injury in the rat. Brain Research 1988; 464: 37–41IS
   PubMedGoogle Scholar
• Przewlocki R., Shearman G. T., Herz A. Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats. Neuropeptides 1983; 3: 233–240
   PubMedGoogle Scholar
• Ruda M. A., Iadarola M. J., Cohen L. V., Young W. S. In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in an rat model of peripheral inflammation and hyperalgesia. Proceedings of the National Academy of Sciences, USA. 1988; 85: 622–626
   PubMedGoogle Scholar
• Spampinato S., Candeletti S. Characterization of dynorphin A-induced antinociception at spinal level. European Journal of Pharmacology 1985; 110: 21–30
   PubMedGoogle Scholar
• Smith A. P., Lee N. M. Pharmacology of dynorphin. Annual Review of Pharmacology & Toxicology 1988; 28: 123–140
   PubMedGoogle Scholar
• Yaksh T. L., Rudy T. A. Chronic catheterization of the spinal subarachnoid space. Physiology and Behavior 1976; 17: 1031–1036
   PubMed Web of Science ®Google Scholar